Overview
RLYB market data
Price History
RLYB price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.59 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.82 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.20 – $17.57 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $85.6 · P/B 0.50 · P/S 99.79.
Company News
Rallybio shares are trading higher after the company announced that it will acquire Avenzo through a merger transaction.Benzinga · Jun 1, 2026, 3:36 PM
Rallybio Shares Resume TradeBenzinga · Jun 1, 2026, 12:37 PM
Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga · Jun 1, 2026, 12:25 PM
Rallybio To Acquire Avenzo Therapeutics; Avenzo Entered Into $215M Private Placement FinancingBenzinga · Jun 1, 2026, 12:07 PM
8-K filing — Rallybio Corp (RLYB)SEC EDGAR · Jun 1, 2026, 12:07 PM
Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News PendingBenzinga · Jun 1, 2026, 11:55 AM